Emerging Therapies in HER 2-Positive Metastatic Breast Cancer

home / insights / her2-mbc
Evolving Landscape of HER2-Targeted Therapy in Breast Cancer

EP. 1: Evolving Landscape of HER2-Targeted Therapy in Breast Cancer

January 11th 2020
Adjuvant Strategies in Early-Stage HER2+ Breast Cancer

EP. 2: Adjuvant Strategies in Early-Stage HER2+ Breast Cancer

January 11th 2020
Impact of the KATHERINE Trial on Early-Stage HER2+ BC

EP. 3: Impact of the KATHERINE Trial on Early-Stage HER2+ BC

January 11th 2020
Early-Stage HER2+ Breast Cancer: The ATEMPT Trial

EP. 4: Early-Stage HER2+ Breast Cancer: The ATEMPT Trial

January 11th 2020
Overview of Neoadjuvant Therapy in HER2+ Breast Cancer

EP. 5: Overview of Neoadjuvant Therapy in HER2+ Breast Cancer

January 11th 2020
HER2+ BC: Selection and Management of Neoadjuvant Therapy

EP. 6: HER2+ BC: Selection and Management of Neoadjuvant Therapy

January 11th 2020
Treatment Strategies for Relapsed/Refractory HER2+ mBC

EP. 7: Treatment Strategies for Relapsed/Refractory HER2+ mBC

January 11th 2020
Unmet Needs in the Management of HER2+ mBC

EP. 8: Unmet Needs in the Management of HER2+ mBC

January 11th 2020
HER2+ Breast Cancer: Evolution of Antibody-Drug Conjugates

EP. 9: HER2+ Breast Cancer: Evolution of Antibody-Drug Conjugates

January 11th 2020
HER2+ mBC: Study Design and Results of DESTINY-Breast01

EP. 10: HER2+ mBC: Study Design and Results of DESTINY-Breast01

January 11th 2020
HER2+ mBC: Addressing ILD in the DESTINY-Breast01 Study

EP. 11: HER2+ mBC: Addressing ILD in the DESTINY-Breast01 Study

January 11th 2020
Evolving Role of Trastuzumab Deruxtecan in HER2+/HER2-Low mBC

EP. 12: Evolving Role of Trastuzumab Deruxtecan in HER2+/HER2-Low mBC

January 11th 2020
Emerging Agents for HER2+ mBC: HER2CLIMB and SOPHIA Trials

EP. 13: Emerging Agents for HER2+ mBC: HER2CLIMB and SOPHIA Trials

January 11th 2020
Emerging Agents for HER2+ mBC: Targeted Therapeutics

EP. 14: Emerging Agents for HER2+ mBC: Targeted Therapeutics

January 11th 2020
Combining Anti-HER2 Agents With Immunotherapy for HER2+ mBC

EP. 15: Combining Anti-HER2 Agents With Immunotherapy for HER2+ mBC

January 11th 2020
Targeting HER2 Outside of Breast Cancer

EP. 16: Targeting HER2 Outside of Breast Cancer

January 11th 2020
Practical Advice on Treating HER2+ Metastatic Breast Cancer

EP. 17: Practical Advice on Treating HER2+ Metastatic Breast Cancer

January 11th 2020
HER2+ Breast Cancer: Future Treatment Landscape

EP. 18: HER2+ Breast Cancer: Future Treatment Landscape

January 11th 2020